Pillstats
Rx only · Tablet, Extended Release · Oral

Pyridostigmine Bromide

Brands: Mestinon · Pyridostigmine Bromide

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)9000
US makers4 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.33$2.66$3.99$5.31Dec 2025Apr 2026Jul 2026
$4.417
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
4
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4559101.4K1.8K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.5K
Rx · 2026 Q1
91K
Units dispensed
+15%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bausch Health US, LLCunknown1SUPPLYING
Alvogen Inc.unknown1SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING
Oceanside Pharmaceuticalsunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.